Enhanced skin permeation of 6-methoxy-2-naphthylacetic acid by salt formation

被引:2
作者
Pawar, Vijay [1 ]
Kumar, H. Yogish [2 ]
Giridhar, Rajani [1 ]
Yadav, Mange Ram [1 ]
机构
[1] Maharaja Sayajirao Univ Baroda, Fac Engn & Technol, Dept Pharm, Vadodara 390001, India
[2] Delhi Inst Pharmaceut Sci & Res DIPSAR, New Delhi, India
关键词
6-MNA; lipophilicity; NSAID; salts; skin permeation; solubility; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PERMEABILITY; NSAIDS;
D O I
10.3109/10717544.2014.894595
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to prepare salts of 6-methoxy-2-naphthylacetic acid (6-MNA) to improve its physicochemical properties for percutaneous application. 6-MNA, an active metabolite of non-steroidal anti-inflammatory drug nabumetone has long half life and has the tendency to penetrate well into synovial fluid. The physicochemical properties of 6-MNA salts were investigated by solubility measurements, differential scanning calorimetry (DSC) and infrared (IR). The DSC thermograms and Fourier transform infrared (FT-IR) spectra indicated that 6-MNA formed salts with organic and alkali metal bases. Among the series, salts formed with amine bases (ethanolamine, diethanolamine, triethanolamine and diethylamine) had lower melting points while alkali metal salt (sodium) had higher melting point than 6-MNA. The salts had higher solubilities than 6-MNA as determined in phosphate buffer at pH 5.0 and 7.4. There is no significant difference in partition coefficient (log P) values between salts and 6-MNA at pH 5.0 but, at pH 7.4, the log P values for the salts increased by 4-10 times as compared to 6-MNA. In vitro permeation studies showed that all the salts increased the flux in comparision to 6-MNA, and the ethanolamine salt (1b) was found to be having 7.7 and 9.4 times higher permeability as compared to 6-MNA at pH 5.0 and 7.4, respectively.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 22 条
  • [11] The effect of meloxicam/ethanolamine salt formation on percutaneous absorption of meloxicam
    Ki, Han-Moe
    Choi, Hoo-Kyun
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2007, 30 (02) : 215 - 221
  • [12] Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe
    Komatsu, Takaaki
    Sakurada, Tsukasa
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 47 (05) : 890 - 895
  • [13] Deep percutaneous penetration into muscles and joints
    Lee, Christine M.
    Maibach, Howard I.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (07) : 1405 - 1413
  • [14] MENASSE R, 1978, SCAND J RHEUMATOL, P5
  • [15] Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk
    Motsko, Stephen P.
    Rascati, Karen L.
    Busti, Anthony J.
    Wilson, James P.
    Barner, Jamie C.
    Lawson, Kenneth A.
    Worchel, Jason
    [J]. DRUG SAFETY, 2006, 29 (07) : 621 - 632
  • [16] Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation
    Rautio, J
    Nevalainen, T
    Taipale, H
    Vepsäläinen, J
    Gynther, J
    Laine, K
    Järvinen, T
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 (02) : 157 - 163
  • [17] Percutaneous absorption of topically applied NSAIDS and other compounds: Role of solute properties, skin physiology and delivery systems
    Roberts M.S.
    Cross S.E.
    [J]. InflammoPharmacology, 1999, 7 (4) : 339 - 350
  • [18] SINGH P, 1994, J PHARMACOL EXP THER, V268, P144
  • [19] TRANSDERMAL DRUG-DELIVERY BY PASSIVE DIFFUSION AND IONTOPHORESIS - A REVIEW
    SINGH, S
    SINGH, J
    [J]. MEDICINAL RESEARCH REVIEWS, 1993, 13 (05) : 569 - 621
  • [20] Suh H, 1997, BIOPHARM DRUG DISPOS, V18, P623, DOI 10.1002/(SICI)1099-081X(199710)18:7<623::AID-BDD46>3.0.CO